Ascend Wellness Holdings (AAWH) Share-based Compensation (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Share-based Compensation came in at $450000.0 in Q1 2026, up 139.51% quarter-over-quarter from -$1.1 million in Q3 2025.
Ascend Wellness Holdings (AAWH) Share-based Compensation (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Share-based Compensation history runs 7 years deep, the most recent figure standing at $450000.0 for Q1 2026.
- On a quarterly basis, Share-based Compensation changed N/A year-over-year to $450000.0 in Q1 2026; TTM through Mar 2026 was $450000.0, a 110.07% increase from a year earlier, with the FY2024 full-year figure at $6.2 million, down 68.41% from the prior year.
- Share-based Compensation rose to $450000.0 in Q1 2026 per AAWH's latest filing, from -$1.1 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $13.9 million in Q3 2023 and bottomed at -$10.9 million in Q3 2024.
- The 5-year median for Share-based Compensation is $1.1 million (2025), against an average of $2.4 million.
- Across the five-year window, Share-based Compensation plunged 181.65% in 2022 and jumped 10616.0% in 2024, its largest moves.
- Year by year, Share-based Compensation stood at $287000.0 in 2022, then soared by 1920.91% to $5.8 million in 2023, then slumped by 79.53% to $1.2 million in 2024, then slumped by 195.96% to -$1.1 million in 2025, then jumped by 139.51% to $450000.0 in 2026.
- Per Business Quant, the three latest AAWH Share-based Compensation figures stand at $450000.0 (Q1 2026), -$1.1 million (Q3 2025), and $1.1 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | 450,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 450,000.00 |
| Mar 31, 2026 | 450,000.00 |
| Sep 30, 2025 | -1.14 Mn |
| Sep 30, 2025 | -1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Jun 30, 2025 | 1.14 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | -10.94 Mn |
| Sep 30, 2024 | -10.94 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Jun 30, 2024 | 5.28 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Mar 31, 2024 | 10.72 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Sep 30, 2023 | 13.88 Mn |
| Mar 31, 2023 | 100,000.00 |
| Mar 31, 2023 | 100,000.00 |